Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangning Liu

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Protein & Cell|April 4, 2022
Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaquesChun-Chun Gao, Man Li, Wei Deng, et al.
Cell|May 20, 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B CellsYunlong Cao, Bin Su, Xianghua Guo, et al.
Science (New York, N.Y.)|May 8, 2020
Development of an inactivated vaccine candidate for SARS-CoV-2Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Virology Journal|December 10, 2022
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variantsGuochao Liao, Hungyan Lau, Zhongqiu Liu, et al.
Animal Models and Experimental Medicine|April 23, 2020
Age-related rhesus macaque models of COVID-19Pin Yu, Feifei Qi, Yanfeng Xu, et al.
Cell|September 24, 2020
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing StrategyShuo Du, Yunlong Cao, Qinyu Zhu, et al.
Nature Biomedical Engineering|July 8, 2025
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsCuifeng Li, Yuxin Li, Bini Zhou, et al.
Nature|May 8, 2020
The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceLinlin Bao, Wei Deng, Baoying Huang, et al.
Signal Transduction and Targeted Therapy|September 26, 2021
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gammaJiejie Geng, Liang Chen, Yufeng Yuan, et al.
Nature Communications|May 21, 2020
Immunogenicity of a DNA vaccine candidate for COVID-19Trevor R F Smith, Ami Patel, Stephanie Ramos, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Protein & Cell|April 4, 2022
Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaquesChun-Chun Gao, Man Li, Wei Deng, et al.
Cell|May 20, 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B CellsYunlong Cao, Bin Su, Xianghua Guo, et al.
Science (New York, N.Y.)|May 8, 2020
Development of an inactivated vaccine candidate for SARS-CoV-2Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Virology Journal|December 10, 2022
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variantsGuochao Liao, Hungyan Lau, Zhongqiu Liu, et al.
Animal Models and Experimental Medicine|April 23, 2020
Age-related rhesus macaque models of COVID-19Pin Yu, Feifei Qi, Yanfeng Xu, et al.
Cell|September 24, 2020
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing StrategyShuo Du, Yunlong Cao, Qinyu Zhu, et al.
Nature Biomedical Engineering|July 8, 2025
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsCuifeng Li, Yuxin Li, Bini Zhou, et al.
Nature|May 8, 2020
The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceLinlin Bao, Wei Deng, Baoying Huang, et al.
Signal Transduction and Targeted Therapy|September 26, 2021
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gammaJiejie Geng, Liang Chen, Yufeng Yuan, et al.
Nature Communications|May 21, 2020
Immunogenicity of a DNA vaccine candidate for COVID-19Trevor R F Smith, Ami Patel, Stephanie Ramos, et al.
Pageof 9